Your Window Into the Innovation Economy

“The Zepbound trade” is shorthand for the GLP-1 seismic shift. What started as a targeted diabetes treatment has evolved into a profound therapeutic breakthrough. GLP-1 receptor agonists like Ozempic, Wegovy, and Zepbound aren’t just changing waistlines — they’re reshaping healthcare and creating a universe of opportunities for visionary investors.

The next generation of wealth statistics show that the transfer of wealth from baby boomers to millennials and Gen Z will be in the trillions of dollars. As this transition unfolds in millions of households, many parents have begun to recognize the importance of preparing their children to manage their future inheritance responsibly.

Tough markets don’t stop great ideas — some of the most game-changing companies were born in downturns. Venture capital isn’t about chasing headlines; it’s about staying patient, focused, and investing in real innovation over time. At Alumni Ventures, we play the long game, backing visionary founders and building portfolios built to thrive through all market cycles.

Seed-stage investing involves high risk and high reward, where bold ideas evolve into products with the potential for significant growth. Investors at this stage focus on assessing key factors such as founder expertise, market potential, product differentiation, and scalability. A diversified approach, thorough due diligence, and strategic involvement with founders can enhance the chances of success in this high-stakes investment space, despite challenges like high failure rates and unproven business models.

There’s a dark side to AI that’s underreported. It’s not deepfakes, mass surveillance, job displacement, or AI takeovers but rather every CISO’s (Chief Information Security Officer’s) worst nightmare. Since the launch of ChatGPT in 2022, employees have been feeding code, emails, and sensitive documents into generative AI tools, opening the floodgates to data leaks and security risks.